Cargando…

Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study

BACKGROUND: Selective reporting is included as a core domain of Cochrane’s tool for assessing risk of bias in randomised trials. There has been no evaluation of review authors’ use of this domain. We aimed to evaluate assessments of selective reporting in a cross-section of Cochrane reviews and to o...

Descripción completa

Detalles Bibliográficos
Autores principales: Page, Matthew J., Higgins, Julian P. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938957/
https://www.ncbi.nlm.nih.gov/pubmed/27392044
http://dx.doi.org/10.1186/s13643-016-0289-2
_version_ 1782441933632700416
author Page, Matthew J.
Higgins, Julian P. T.
author_facet Page, Matthew J.
Higgins, Julian P. T.
author_sort Page, Matthew J.
collection PubMed
description BACKGROUND: Selective reporting is included as a core domain of Cochrane’s tool for assessing risk of bias in randomised trials. There has been no evaluation of review authors’ use of this domain. We aimed to evaluate assessments of selective reporting in a cross-section of Cochrane reviews and to outline areas for improvement. METHODS: We obtained data on selective reporting judgements for 8434 studies included in 586 Cochrane reviews published from issue 1–8, 2015. One author classified the reasons for judgements of high risk of selective reporting bias. We randomly selected 100 reviews with at least one trial rated at high risk of outcome non-reporting bias (non-/partial reporting of an outcome on the basis of its results). One author recorded whether the authors of these reviews incorporated the selective reporting assessment when interpreting results. RESULTS: Of the 8434 studies, 1055 (13 %) were rated at high risk of bias on the selective reporting domain. The most common reason was concern about outcome non-reporting bias. Few studies were rated at high risk because of concerns about bias in selection of the reported result (e.g. reporting of only a subset of measurements, analysis methods or subsets of the data that were pre-specified). Review authors often specified in the risk of bias tables the study outcomes that were not reported (84 % of studies) but less frequently specified the outcomes that were partially reported (61 % of studies). At least one study was rated at high risk of outcome non-reporting bias in 31 % of reviews. In the random sample of these reviews, only 30 % incorporated this information when interpreting results, by acknowledging that the synthesis of an outcome was missing data that were not/partially reported. CONCLUSIONS: Our audit of user practice in Cochrane reviews suggests that the assessment of selective reporting in the current risk of bias tool does not work well. It is not always clear which outcomes were selectively reported or what the corresponding risk of bias is in the synthesis with missing outcome data. New tools that will make it easier for reviewers to convey this information are being developed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-016-0289-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4938957
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49389572016-07-10 Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study Page, Matthew J. Higgins, Julian P. T. Syst Rev Research BACKGROUND: Selective reporting is included as a core domain of Cochrane’s tool for assessing risk of bias in randomised trials. There has been no evaluation of review authors’ use of this domain. We aimed to evaluate assessments of selective reporting in a cross-section of Cochrane reviews and to outline areas for improvement. METHODS: We obtained data on selective reporting judgements for 8434 studies included in 586 Cochrane reviews published from issue 1–8, 2015. One author classified the reasons for judgements of high risk of selective reporting bias. We randomly selected 100 reviews with at least one trial rated at high risk of outcome non-reporting bias (non-/partial reporting of an outcome on the basis of its results). One author recorded whether the authors of these reviews incorporated the selective reporting assessment when interpreting results. RESULTS: Of the 8434 studies, 1055 (13 %) were rated at high risk of bias on the selective reporting domain. The most common reason was concern about outcome non-reporting bias. Few studies were rated at high risk because of concerns about bias in selection of the reported result (e.g. reporting of only a subset of measurements, analysis methods or subsets of the data that were pre-specified). Review authors often specified in the risk of bias tables the study outcomes that were not reported (84 % of studies) but less frequently specified the outcomes that were partially reported (61 % of studies). At least one study was rated at high risk of outcome non-reporting bias in 31 % of reviews. In the random sample of these reviews, only 30 % incorporated this information when interpreting results, by acknowledging that the synthesis of an outcome was missing data that were not/partially reported. CONCLUSIONS: Our audit of user practice in Cochrane reviews suggests that the assessment of selective reporting in the current risk of bias tool does not work well. It is not always clear which outcomes were selectively reported or what the corresponding risk of bias is in the synthesis with missing outcome data. New tools that will make it easier for reviewers to convey this information are being developed. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-016-0289-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-08 /pmc/articles/PMC4938957/ /pubmed/27392044 http://dx.doi.org/10.1186/s13643-016-0289-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Page, Matthew J.
Higgins, Julian P. T.
Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
title Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
title_full Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
title_fullStr Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
title_full_unstemmed Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
title_short Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
title_sort rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938957/
https://www.ncbi.nlm.nih.gov/pubmed/27392044
http://dx.doi.org/10.1186/s13643-016-0289-2
work_keys_str_mv AT pagematthewj rethinkingtheassessmentofriskofbiasduetoselectivereportingacrosssectionalstudy
AT higginsjulianpt rethinkingtheassessmentofriskofbiasduetoselectivereportingacrosssectionalstudy